PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
-2.53%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$2.17B
AUM Growth
+$2.17B
(-8.4%)
Cap. Flow
-$68.3M
Cap. Flow
% of AUM
-3.15%
Top 10 Holdings %
Top 10 Hldgs %
36.12%
Holding
88
New
9
Increased
22
Reduced
22
Closed
13
Top Buys
| 1 |
Becton Dickinson
BDX
|
$37.4M |
| 2 |
DexCom
DXCM
|
$33.5M |
| 3 |
Legend Biotech
LEGN
|
$22.8M |
| 4 |
Acadia Healthcare
ACHC
|
$22.5M |
| 5 |
Ascendis Pharma
ASND
|
$21.7M |
Top Sells
| 1 |
Cigna
CI
|
$46.8M |
| 2 |
Biogen
BIIB
|
$43.1M |
| 3 |
AstraZeneca
AZN
|
$39.1M |
| 4 |
Axsome Therapeutics
AXSM
|
$30M |
| 5 |
Agilent Technologies
A
|
$27.5M |
Sector Composition
| 1 | Healthcare | 95.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
76
DELISTED
Blueprint Medicines
BPMC
| – | – |
-130,366
| Closed | -$5.71M |
|
|
77
Cigna
CI
$80.3B
| – | – |
-141,300
| Closed | -$46.8M |
|
78
Charles River Laboratories
CRL
$7.94B
| – | – |
-72,820
| Closed | -$15.9M |
|
79
iTeos Therapeutics
ITOS
| – | – |
-70,922
| Closed | -$1.39M |
|
80
Jazz Pharmaceuticals
JAZZ
$7.87B
| – | – |
0
| – | – |
|
81
Johnson & Johnson
JNJ
$429B
| – | – |
-137,746
| Closed | -$24.3M |
|
82
Labcorp
LH
$22.8B
| – | – |
-13,561
| Closed | -$3.19M |
|
83
Pulmonx
LUNG
$70.5M
| – | – |
-1,455,770
| Closed | -$12.3M |
|
|
JNCE
84
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| – | – |
-345,926
| Closed | -$384K |
|
|
OSH
85
DELISTED
Oak Street Health, Inc.
OSH
| – | – |
-565,239
| Closed | -$12.2M |
|